HealthSouth Corporation (HLS) Reaffirms 2014 Guidance

HealthSouth Corporation (NYSE: HLS) will participate in the Baird 2014 Healthcare Conference in New York on September 3-4, 2014. HealthSouth Executive Vice President and Chief Operating Officer, Mark Tarr, will participate in a fireside chat presentation on Wednesday, September 3rd at 2:55 p.m. ET and reference selected slides previously included in the Investor Reference Book attached as Exhibit 99.1 (the “Investor Reference Book”) to the Current Report on Form 8‑K dated August 20, 2014. The presentation will address, among other things, the Company's strategy and financial performance and discuss industry trends and dynamics. The presentations will be webcast live and will be available at http://investor.healthsouth.com by clicking on an available link.

The Company will provide its observations that volumes in July and August 2014 were in line with its guidance considerations of 4.3% to 5.3% for the second half of 2014. As a reminder, discharge growth for the third quarter of 2014 will include new-store growth from the consolidation of Fairlawn Rehabilitation Hospital in Worcester, Massachusetts. New-store growth in the third quarter of 2013 included the acquisition of Walton Rehabilitation Hospital in Augusta, Georgia and three de novo hospitals (Ocala, Florida; Littleton, Colorado; and Stuart, Florida). The Company will also reiterate its 2014 guidance, as previously disclosed in the Current Reports on Form 8-K dated August 20, 2014 and July 28, 2014 and during the Company's earnings conference call held on July 29, 2014. That is, the Company still expects to be within the following ranges:

• Adjusted EBITDA of $570 to $580 million; and
• Earnings per share from continuing operations attributable to HealthSouth of $2.25 to $2.31.

In addition, on August 29, 2014, the Company gave notice to noteholders of its intent to redeem the remaining $271.4 million aggregate principal amount of its outstanding 7.25% senior notes due 2018 when they become callable in October 2014.
The information contained herein is being furnished pursuant to Item 7.01 of Form 8-K, “Regulation FD Disclosure.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• IDEX Corp. (IEX) Tops Q1 EPS by 13c ; Offers Guidance
• Steel Dynamics (STLD) Tops Q1 EPS by 16c